Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis
- PMID: 16238675
- DOI: 10.1111/j.1365-2796.2005.01556.x
Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis
Abstract
Apolipoprotein (apo) B exists in two forms apoB100 and apoB48. ApoB100 is present on very low-density lipoproteins (VLDL), intermediate density lipoproteins (IDL) and LDL. ApoB100 assembles VLDL particles in the liver. This process starts by the formation of a pre-VLDL, which is retained in the cell unless converted to the triglyceride-poor VLDL2. VLDL2 is secreted or converted to VLDL1 by a bulk lipidation in the Golgi apparatus. ApoB100 has a central role in the development of atherosclerosis. Two proteoglycan-binding sequences in apoB100 have been identified, which are important for retaining the lipoprotein in the intima of the artery. Retention is essential for the development of the atherosclerotic lesion.
Similar articles
-
Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.Nature. 2002 Jun 13;417(6890):750-4. doi: 10.1038/nature00804. Nature. 2002. PMID: 12066187
-
Enhanced conversion of triglyceride-rich lipoproteins and increased low-density lipoprotein removal in LPLS447X carriers.Arterioscler Thromb Vasc Biol. 2005 Nov;25(11):2410-5. doi: 10.1161/01.ATV.0000188506.79946.ce. Epub 2005 Sep 29. Arterioscler Thromb Vasc Biol. 2005. PMID: 16195478 Clinical Trial.
-
Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.Arterioscler Thromb Vasc Biol. 2006 Jun;26(6):1350-6. doi: 10.1161/01.ATV.0000219695.84644.56. Epub 2006 Mar 30. Arterioscler Thromb Vasc Biol. 2006. PMID: 16574893 Clinical Trial.
-
In vivo studies of VLDL metabolism and LDL heterogeneity.Eur Heart J. 1998 Jul;19 Suppl H:H7-10. Eur Heart J. 1998. PMID: 9717058 Review.
-
Heterogeneity of apolipoprotein B-100-containing lipoproteins: what we have learnt from kinetic studies.Curr Opin Lipidol. 1998 Jun;9(3):197-202. doi: 10.1097/00041433-199806000-00003. Curr Opin Lipidol. 1998. PMID: 9645501 Review.
Cited by
-
Elevated apolipoprotein B predicts poor postsurgery prognosis in patients with hepatocellular carcinoma.Onco Targets Ther. 2019 Mar 12;12:1957-1964. doi: 10.2147/OTT.S192631. eCollection 2019. Onco Targets Ther. 2019. PMID: 30881047 Free PMC article.
-
Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans.J Clin Invest. 2009 May;119(5):1322-34. doi: 10.1172/JCI37385. Epub 2009 Apr 20. J Clin Invest. 2009. PMID: 19381015 Free PMC article.
-
Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target.Metabolites. 2021 Oct 8;11(10):690. doi: 10.3390/metabo11100690. Metabolites. 2021. PMID: 34677405 Free PMC article. Review.
-
Apolipoprotein B100 acts as a tumor suppressor in ovarian cancer via lipid/ER stress axis-induced blockade of autophagy.Acta Pharmacol Sin. 2025 May;46(5):1445-1461. doi: 10.1038/s41401-024-01470-x. Epub 2025 Jan 29. Acta Pharmacol Sin. 2025. PMID: 39880927
-
Nanotubes functionalized with lipids and natural amino acid dendrimers: a new strategy to create nanomaterials for delivering systemic RNAi.Bioconjug Chem. 2010 Jan;21(1):56-63. doi: 10.1021/bc900296z. Bioconjug Chem. 2010. PMID: 19957956 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical